Connect with us

Health

Researchers: No added risk of death with drug-coated devices used for lower body procedure – EurekAlert

Cardiologists at Beth Israel Deaconess Medical Center (BIDMC), designed the Safety Assessment of Femoropopliteal Endovascular Treatment With Paclitaxel-coated Devices…

Published

on

Article feature image

BOSTON – Peripheral artery disease (PAD), or blockages in the arteries outside of the heart, affects more than 200 million people worldwide and 12.5 million people in the United States. Patients with this circulatory disorder may develop severe leg pain or unhealing wounds that require a minimally invasive revascularization procedure to open the blood vessels to improve blood flow.
For nearly a decade, proceduralists and surgeons have depended on devices coated with a drug called paclitaxel –…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

The Sleep Disorder Therapeutics Market To Witness An Astonishing Growth In The Next 10 Years – The Courier – The Courier
Article feature image
Emerging SARS-CoV-2 variants contain mutations that interfere with genomic sequencing – News-Medical.Net